Key result
Cobas c702 analyzer reliably measures nine biochemical assays in pericardial fluid with acceptable precision.
Why the study?
Biochemical analysis of pericardial fluid can aid in determining the etiology of pericardial effusions.
The Roche Cobas c702 analyzer provides valid and reliable automated biochemical analysis for 9 analytes in pericardial fluid without significant matrix effects.
Validates Cobas c702 assays for pericardial fluid analysis; supports etiology workup but leaves open clinical outcome validation.
BACKGROUND: Biochemical analysis of pericardial fluid (PF) can aid in the determination of the etiology of pericardial effusions. We validated 9 assays for albumin, amylase, blood urea nitrogen, cholesterol, direct and total bilirubin, lactate, lactate dehydrogenase, and total protein on the Roche Cobas c702 analyzer for PF. METHODS: For each analyte, a recovery study was conducted to assess the effect of matrix; intra- and interassay precisions were determined at 3 levels; linearity was evaluated using 5 concentrations across the analytical measurement range; common interferences of hemoglobin, bilirubin, and triglycerides were investigated; and the stability at 22°C up to 7 days, 2°C to 8°C up to 14 days, and -20°C up to 4 weeks was studied. RESULTS: For all analytes, the recoveries were within 90% to 110%; the coefficient of variation ranged from 0% to 6% for intraassay and 1.1% to 6.9% for interassay precision. All assays exhibited linear response; the slopes ranged from 0.99 to 1.008, and R2 ranged from 0.999 to 1.000. No significant interferences of hemoglobin, bilirubin, or lipids were observed for all analytes except for direct bilirubin, which was negatively affected by hemoglobin and lipids. At -20°C, all analytes were stable for 4 weeks. At 2°C to 8°C, all were stable for 14 days except lactate dehydrogenase (2 days) and direct bilirubin (2 days). At 22°C, all were stable for 7 days except for direct bilirubin (8 hours) and total bilirubin (3 days). CONCLUSION: No matrix effects were observed with the assays for these 9 analytes in PF on the Cobas c702 analyzer.
No takes yet. Share an insight, caveat, or question.
Maher et al. (2026) studied Pericardial effusions. Automated biochemical analysis on the Roche Cobas c702 analyzer was evaluated on Assay recovery, precision, linearity, interference, and stability. Nine biochemical assays for pericardial fluid on the Cobas c702 analyzer showed acceptable recovery (90-110%), precision (CV ≤6.9%), and linearity without significant matrix effects.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: